Search

To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.worlddev.2005.07.010 Byline: Joanna Chataway Keywords: HIV/AIDS; public-private partnerships; advocacy; capacity building; Africa; India Abstract: Product based public-private partnerships (PPPs), of which the International Aids Vaccine Initiative (IAVI) is one, are being developed to try and bridge the gap between scientific and technological potential and the needs of developing countries. First, this paper examines PPP's popularity. Second, we describe key characteristics of IAVI and explain why it differs from more traditional partnerships. Third, IAVI has had some success in bringing new science and technology closer to the world's poor and we look at how it has achieved this success and implications for theoretical and practical approaches to science and technology capacity building. Author Affiliation: ESRC INNOGEN Research Centre, The Open University, UK Article History: Accepted 25 July 2005

Product based public-private partnerships (PPPs), of which the International Aids Vaccine Initiative (IAVI) is one, are being developed to try and bridge the gap between scientific and technological potential and the needs of developing countries. First, this paper examines PPP's popularity. Second, we describe key characteristics of IAVI and explain why it differs from more traditional partnerships. Third, IAVI has had some success in bringing new science and technology closer to the world's poor and we look at how it has achieved this success and implications for theoretical and practical approaches to science and technology capacity building. Key words--HIV/AIDS, public private partnerships, advocacy, capacity building, Africa, India

Byline: Joanna Chataway, David Wield This paper examines R&D and strategic decision-making in firms, reviewing institutional and market constraints that act on the development of bio- and new materials technologies. The findings are assessed against the background of biotechnology and new materials as potential 'core technologies' that, combined with new socioeconomic norms, will make up a significantly different technoeconomic paradigm for the next century. The studies presented portray levels of complexity that highlight the variety of technological evolution. They also illustrate the need for improved methods of analysis that better integrate macro- and micro-levels of evolutionary theory.

Author(s): Joanna Chataway, Rebecca Hanlin Author Affiliations: Grant winners: Track social impact of grant types in Africa African grant-giving bodies need more evidence on the economic and social impact of [...]

Byline: Joanna Chataway, James Smith, David Wield Science and technology - and particularly biotechnology - is increasingly central to development agendas in Africa and elsewhere. Implicit within the centrality of science and technology lie a set of policy issues regarding how best to shape contextually appropriate, innovative and sustainable science and technological products in, with and for developing countries. The work of the Consultative Group on International Agricultural Research (CGIAR) is a case in point and we draw our empirical material from the evolution of two biotech bovine vaccine development programmes housed in a CG Centre. In the paper, we seek to show that broadening our understanding of scientific 'excellence' can lead to more innovative, systemic research that may produce more appropriate technological solutions. We believe this has key implications for science policy, development policy and the practice of science for development itself.